


Brigham Mesothelioma Researchers Investigate Women’s Better Survival Rates
A recent study authored by researchers from the International Mesothelioma Program of the Brigham & Women’s Hospital (IMP) and others has examined the correlation of estrogen and the incidence and survival of mesothelioma. The article describing the study,...
New Mesothelioma Drug Fast Tracked by FDA
The immunotherapy drug ONCOS-102 has been granted Fast Track designation by the Food and Drug Administration (FDA). Fast Track designation speeds up the regulatory review process for the drug. What Is ONCOS-102? ONCOS-102 is an immune activator designed for pleural...
EPA Must Fully Protect Americans From Asbestos Exposure and Mesothelioma
In May of 2020, the Environmental Protection Agency (EPA) published a review of continuing dangers associated with asbestos, pursuant to the the amended Toxic Substances Control Act (TSCA). This risk evaluation was widely criticized by scientists and...
EPA Issues Inadequate Draft Asbestos Risk Evaluation
The Environmental Protection Agency (EPA) recently issued a Draft Asbestos Risk Evaluation that will keep Americans at severe risk of deadly exposure to asbestos according to the Asbestos Disease Awareness Organization. The ADAO, an independent nonprofit dedicated to...